A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2 (2023)

First Author: Zanti M
Attributed to:  Evaluating new healthcare technologies in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1155/2023/9961341

Publication URI: http://dx.doi.org/10.1155/2023/9961341

Type: Journal Article/Review

Parent Publication: Human Mutation